23 related articles for article (PubMed ID: 15030987)
1. A statistical method for removing unbalanced trials with multiple covariates in meta-analysis.
Attanasio M; Aiello F; Tinè F
PLoS One; 2023; 18(12):e0295332. PubMed ID: 38100399
[TBL] [Abstract][Full Text] [Related]
2. The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.
Hassanein T; Shiffman ML; Zein NN
Gastroenterol Hepatol (N Y); 2007 Jun; 3(6 Suppl 20):4-32. PubMed ID: 23329897
[No Abstract] [Full Text] [Related]
3. Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.
Chung RT; Umbleja T; Chen JY; Andersen JW; Butt AA; Sherman KE;
HIV Clin Trials; 2012; 13(2):70-82. PubMed ID: 22510354
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.
Dahari H; Guedj J; Perelson AS; Layden TJ
Curr Hepat Rep; 2011 Jul; 10(3):214-227. PubMed ID: 22180724
[TBL] [Abstract][Full Text] [Related]
5. Antiviral treatment of chronic hepatitis C in clinical routine.
Maieron A; Metz-Gercek S; Hackl F; Ziachehabi A; Fuchsteiner H; Luger C; Mittermayer H; Schöfl R
Wien Klin Wochenschr; 2010 Apr; 122(7-8):237-42. PubMed ID: 20503023
[TBL] [Abstract][Full Text] [Related]
6. Alkaline phosphatase predicts relapse in chronic hepatitis C patients with end-of-treatment response.
Bodlaj G; Hubmann R; Saleh K; Stojakovic T; Biesenbach G; Berg J
World J Gastroenterol; 2010 May; 16(19):2407-10. PubMed ID: 20480527
[TBL] [Abstract][Full Text] [Related]
7. Extended-therapy duration for chronic hepatitis C, genotype 1: the long and the short of it.
Pearlman BL
World J Gastroenterol; 2008 Jun; 14(23):3621-7. PubMed ID: 18595128
[TBL] [Abstract][Full Text] [Related]
8. [Is combination therapy of chronic hepatitis C with interferon alpha and ribavirin in primary interferon nonresponders indicated?--An analysis of personal experiences and review of the literature].
Wedemeyer H; Jäckel E; Wedemeyer J; Frank H; Schüler A; Trautwein C; Manns MP
Z Gastroenterol; 1998 Sep; 36(9):819-27. PubMed ID: 9795411
[TBL] [Abstract][Full Text] [Related]
9. Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients.
Brouwer JT; Nevens F; Bekkering FC; Bourgeois N; Van Vlierberghe H; Weegink CJ; Lefebvre V; Van Hattum J; Henrion J; Delwaide J; Hansen BE; Schalm SW;
J Hepatol; 2004 Apr; 40(4):689-95. PubMed ID: 15030987
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.
Shiffman ML; Hofmann CM; Gabbay J; Luketic VA; Sterling RK; Sanyal AJ; Contos MJ; Ryan MJ; Yoshida C; Rustgi V
Am J Gastroenterol; 2000 Oct; 95(10):2928-35. PubMed ID: 11051370
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone.
Min AD; Jones JL; Esposito S; Lebovics E; Jacobson IM; Klion FM; Goldman IS; Geders JM; Tobias H; Bodian C; Bodenheimer HC
Am J Gastroenterol; 2001 Apr; 96(4):1143-9. PubMed ID: 11316161
[TBL] [Abstract][Full Text] [Related]
12. Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378].
Veldt BJ; Brouwer JT; Adler M; Nevens F; Michielsen P; Delwaide J; Hansen BE; Schalm SW;
BMC Gastroenterol; 2003 Aug; 3():24. PubMed ID: 12948399
[TBL] [Abstract][Full Text] [Related]
13. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
14. Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin.
Zilly M; Lingenauber C; Desch S; Väth T; Klinker H; Langmann P
Eur J Med Res; 2002 Apr; 7(4):149-54. PubMed ID: 12010649
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
